Company intelligence / Profile preview

Hangzhou Rebtech Novel Material

Hangzhou, Zhejiang, China

Ownership: Private
Employees: ~20
Development stage: Other

Overview

Hangzhou Rebtech provides a range of cosmetic and pharmaceutical raw materials, including innovative small molecules and peptides for skin care and health applications, with commercial scale supply for domestic and global markets

Therapeutic areas: OphthalmologyDermatologyCardiovascular
Modalities: Small moleculePeptidesBiologicNanoparticle (e.g., gold nanorods)ProteinVitamin derivativesAmino compound derivatives
Industry: Chemicals & Materials

Partnerships

Collaboration with Zhejiang University of Technology for R&DDistributors in Asia, Europe, AmericaWell-known formulation companies in Europe and America

Beyond the preview

Go deeper on Hangzhou Rebtech Novel Material.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hangzhou Rebtech Novel Material.

Explore the full profile